|
Volumn 42, Issue 2, 2002, Pages 137-139
|
Linezolid-resistant Enterococcus faecium isolated from a patient without prior exposure to an oxazolidinone: Report from the SENTRY Antimicrobial Surveillance Program
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMOXICILLIN PLUS CLAVULANIC ACID;
AMPICILLIN;
CARBAPENEM;
CHLORAMPHENICOL;
CIPROFLOXACIN;
COTRIMOXAZOLE;
DALFOPRISTIN PLUS QUINUPRISTIN;
DOXYCYCLINE;
ERYTHROMYCIN;
GENTAMICIN;
IMIPENEM;
LEVOFLOXACIN;
LINEZOLID;
MACROLIDE;
NITROFURANTOIN;
OXAZOLIDINONE DERIVATIVE;
PENICILLIN G;
PIPERACILLIN PLUS TAZOBACTAM;
POSIZOLID;
PSEUDOMONIC ACID;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
RIBOSOME RNA;
RIFAMPICIN;
STREPTOMYCIN;
TEICOPLANIN;
UNCLASSIFIED DRUG;
VANCOMYCIN;
ADULT;
ANTIBIOTIC RESISTANCE;
ARTICLE;
BACTERIUM IDENTIFICATION;
BACTERIUM ISOLATE;
CASE REPORT;
CLINICAL FEATURE;
DIFFUSION;
DISEASE COURSE;
DRUG SURVEILLANCE PROGRAM;
ENTEROCOCCUS FAECIUM;
GENE MUTATION;
HUMAN;
KIDNEY FAILURE;
LABORATORY;
MALE;
MINIMUM INHIBITORY CONCENTRATION;
PRIORITY JOURNAL;
ACETAMIDES;
ADULT;
ANTI-BACTERIAL AGENTS;
DRUG RESISTANCE, BACTERIAL;
ENTEROCOCCUS FAECIUM;
GRAM-POSITIVE BACTERIAL INFECTIONS;
HUMANS;
MALE;
MICROBIAL SENSITIVITY TESTS;
OXAZOLIDINONES;
POPULATION SURVEILLANCE;
|
EID: 0036177450
PISSN: 07328893
EISSN: None
Source Type: Journal
DOI: 10.1016/S0732-8893(01)00333-9 Document Type: Article |
Times cited : (102)
|
References (12)
|